Nimotask intravenous solution contains nimodipine, which belongs to the calcium channel blocker class of medications.
It is used to help improve blood flow to the brain after certain types of cerebral hemorrhage.
The medication works by reducing blood vessel spasm and improving cerebral circulation. It is administered in
hospitals under strict medical supervision and requires continuous monitoring of blood pressure and the patient’s
overall condition during treatment.
Composition of Nimotask
Nimotask contains the following active ingredient:
Dosage Form of Nimotask
Nimotask is available as an intravenous infusion vial containing 50 ml solution with nimodipine 10 mg.
Indications for Nimotask
Main uses include:
Assisting in the treatment of cerebral vasospasm
Improving cerebral blood flow after subarachnoid hemorrhage
Reducing spasm of cerebral blood vessels
Supporting cerebral circulation in critical conditions
Hospital use under medical supervision
Dosage of Nimotask
The medication is administered by slow intravenous infusion under specialized medical supervision. The appropriate
dose is determined according to the patient’s weight and medical condition.
Continuous blood pressure monitoring is required during treatment to ensure safe use. Nimotask is intended for
hospital use only, and the dose should not be changed or discontinued without consulting the treating physician.
Side Effects of Nimotask
Common side effects may include:
Low blood pressure
Headache
Dizziness and fatigue
Increased heart rate
Nausea
Facial flushing
Contraindications of Nimotask
Nimotask should not be used in patients with hypersensitivity to nimodipine or any of the product’s ingredients. It is
also contraindicated in cases of severe hypotension or when used with certain medications that affect liver enzymes
unless approved by a physician.
Caution is required in patients with liver or heart disease, and the medication should only be used under specialized
medical supervision inside the hospital.
Alternatives to Nimotask
Available alternatives include:
Proper Use of Nimotask
The medication is administered only through intravenous infusion and must be given by healthcare professionals to
ensure proper and safe use.
Vital signs should be monitored continuously throughout treatment. Sudden discontinuation should be avoided without
medical guidance, and strict adherence to the prescribed dosage schedule is necessary according to the patient’s
condition.
Storage Conditions
Store at the recommended temperature according to the leaflet
Keep away from direct light
Keep out of reach of children
Do not freeze the solution
Store in the original package